These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35266851)

  • 1. Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Cell Cycle; 2022 Jun; 21(12):1294-1315. PubMed ID: 35266851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific V-ATPase expression sub-classifies IDHwt lower-grade gliomas and impacts glioma growth in vivo.
    Terrasi A; Bertolini I; Martelli C; Gaudioso G; Di Cristofori A; Storaci AM; Formica M; Bosari S; Caroli M; Ottobrini L; Vaccari T; Vaira V
    EBioMedicine; 2019 Mar; 41():214-224. PubMed ID: 30737087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and validation of a novel integrin-based prognostic gene signature that sub-classifies gliomas and effectively predicts immunosuppressive microenvironment.
    Qi C; Lei L; Hu J; Ou S
    Cell Cycle; 2023 May; 22(10):1259-1283. PubMed ID: 37096960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent mutations of genes encoding vacuolar H
    Sekimizu M; Yoshida A; Mitani S; Asano N; Hirata M; Kubo T; Yamazaki F; Sakamoto H; Kato M; Makise N; Mori T; Yamazaki N; Sekine S; Oda I; Watanabe SI; Hiraga H; Yonemoto T; Kawamoto T; Naka N; Funauchi Y; Nishida Y; Honoki K; Kawano H; Tsuchiya H; Kunisada T; Matsuda K; Inagaki K; Kawai A; Ichikawa H
    Genes Chromosomes Cancer; 2019 Jun; 58(6):373-380. PubMed ID: 30597645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma.
    Luo X; Wang Q; Tang H; Chen Y; Li X; Chen J; Zhang X; Li Y; Sun J; Han S
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676646
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutational profiling of low-grade gliomas identifies prognosis and immunotherapy-related biomarkers and tumour immune microenvironment characteristics.
    Lin WW; Ou GY; Zhao WJ
    J Cell Mol Med; 2021 Nov; 25(21):10111-10125. PubMed ID: 34597473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into V-ATPase functioning: distinct roles for its accessory subunits ATP6AP1/Ac45 and ATP6AP2/(pro) renin receptor.
    Jansen EJ; Martens GJ
    Curr Protein Pept Sci; 2012 Mar; 13(2):124-33. PubMed ID: 22044156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Oncol Lett; 2021 Apr; 21(4):252. PubMed ID: 33664816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas.
    Chen S; Zhang S; Wang Z; Li J; Yuan Y; Li T; Zuo M; Feng W; Li W; Chen M; Liu Y
    Front Pharmacol; 2022; 13():1038272. PubMed ID: 36438805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an ATP metabolism-related signature associated with prognosis and immune microenvironment in gliomas.
    Huang R; Li G; Wang Z; Hu H; Zeng F; Zhang K; Wang K; Wu F
    Cancer Sci; 2020 Jul; 111(7):2325-2335. PubMed ID: 32415873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analyses reveal the role of histone deacetylase genes in prognosis and immune response in low-grade glioma.
    Shen L; Li Y; Li N; Shen L; Li Z
    PLoS One; 2022; 17(10):e0276120. PubMed ID: 36227941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
    Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
    Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma.
    Zhang S; Chen S; Wang Z; Li J; Yuan Y; Feng W; Li W; Chen M; Liu Y
    Front Pharmacol; 2022; 13():1061597. PubMed ID: 36386216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes.
    Bertolini I; Terrasi A; Martelli C; Gaudioso G; Di Cristofori A; Storaci AM; Formica M; Braidotti P; Todoerti K; Ferrero S; Caroli M; Ottobrini L; Vaccari T; Vaira V
    EBioMedicine; 2019 Mar; 41():225-235. PubMed ID: 30737083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of individual domains and the significance of shedding of ATP6AP2/(pro)renin receptor in vacuolar H(+)-ATPase biogenesis.
    Kinouchi K; Ichihara A; Sano M; Sun-Wada GH; Wada Y; Ochi H; Fukuda T; Bokuda K; Kurosawa H; Yoshida N; Takeda S; Fukuda K; Itoh H
    PLoS One; 2013; 8(11):e78603. PubMed ID: 24223829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
    Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
    BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
    Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
    Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in glioma.
    Luo H; Ye M; Hu Y; Wu M; Cheng M; Zhu X; Huang K
    Aging (Albany NY); 2022 Sep; 14(19):7824-7850. PubMed ID: 36152044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and immunological value of
    Wang J; Liu Y; Zhang S
    Aging (Albany NY); 2021 Jul; 13(13):16904-16921. PubMed ID: 34228637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology.
    Mehani B; Asanigari S; Chung HJ; Dazelle K; Singh A; Hannenhalli S; Aldape K
    Acta Neuropathol Commun; 2022 Feb; 10(1):19. PubMed ID: 35144680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.